Unicycive Therapeutics 更新 FDA A 类会议情况,并预计在年底前重新提交 Olc NDA
Unicycive Therapeutics 更新 FDA A 类会议情况,并预计在年底前重新提交 Olc NDA
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.